Pulmonary hypertension (PH) is a classic pathophysiological consequence of left-sided valvular heart disease (VHD).
severity of VHD, Doppler echocardiography is a key tool in diagnosis of PH and assessment of its repercussion on right ventricular function. Assessment of pulmonary arterial pressure during exercise stress echocardiography may provide additional prognostic information beyond resting evaluation. Cardiac magnetic resonance is also useful for assessing right ventricular geometry and function, which provide additional prognostic information in patients with VHD and PH. In this paper, we review all relevant studies reporting mechanism, prevalence, and impact on outcomes of PH in patients with left-sided VHD. The final selection of discussed studies was based on the authors' consensus regarding robustness of data, sample size, and quality of methodology. Furthermore, in this specific clinical setting and in the likely diagnosis of PH using echocardiography (Table 1) , the requirement of invasive measurement of PAP could be debated. Nuclear imaging has little use in this setting except to rule out ischemic heart disease, detect viable myocardium, and evaluate ventricular function. Similar information can be obtained with cardiac magnetic resonance, the main role of which is to evaluate the consequences/causes of VHD.
In some cases, invasive hemodynamic evaluation with right heart catheterization is required to confirm the diagnosis because echocardiography often underestimates the systolic PAP and does not provide an accurate assessment of PCWP (or mean PAP). Magne et al. In patients with VHD, although there are overt limitations in some patients pertaining to the inability to detect TR and accurately measure its peak velocity, the most commonly used technique to estimate systolic PAP remains the direct measurement of peak TR jet velocity, which, according to the simplified Bernoulli equation (peak gradient ¼ 4v
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2 ), provides the derived RV systolic pressure. The systolic PAP is the sum of RV þ right atrial (RA) pressures. The RA pressure may be derived from the inferior vena cava diameter and its changes during the respiratory cycle (6, 7) . Based upon the measurement of peak TR jet velocity and some basic echocardiographic features of PH, the following algorithm has been suggested to identify PH ( The assessment of PH includes measurements of tricuspid regurgitation (TR) peak velocity (A), pulmonary acceleration time (AcT) (B), and inferior vena cava diameter (C). RA ¼ right atrium; other abbreviation as in Figure 1 .
The LV eccentricity index (i.e., the ratio of the LV anteroposterior to septolateral diameters in short-axis view), measured just slightly above the papillary muscles, is one of the parameters that can be used to detect changes in RV shape, providing quantitative assessment of septal flattening. In normal states, the LV eccentricity index is 1, both in systole and diastole.
By echocardiography, RV function can be evaluated using multiple parameters, among which the fractional area change, tricuspid annular systolic plane, and peak systolic tricuspid annular velocity are the most common ( Table 2 elliptical. With 3D echocardiography, the actual geometry of the flow convergence and the tricuspid annulus can be evaluated without any geometric assumptions. To date, data derived from 3D echocardiography are still limited. When the imaging quality is poor, cardiac magnetic resonance can be used to evaluate the severity of TR.
AORTIC STENOSIS
PREVALENCE. The prevalence of PH varies considerably over studies (19) (20) (21) (22) (23) (24) , according to patient selection criteria and the threshold used to define PH (Table 3) . Resting PH has been reported echocardiographically in up to 15% to 30% (>19% mild: >10% to Such an improvement seems greater in patients with higher pre-operative PCWP (27) . and reduced overall cardiac event-free survival in patients with asymptomatic severe AS. Exercise PH doubled the risk of cardiac events in these patients ( Figure 5A ) and had an incremental prognostic value beyond AS severity parameters (i.e., peak aortic jet velocity <4 m/s). Patients with exercise PH require a closer follow-up to rapidly identify the onset of symptoms. When peak aortic jet velocity is >4 m/s and exercise PH is observed, patients might be referred for elective AVR. Conversely, in the absence of exercise PH, patients can be followed up safely.
MITRAL STENOSIS
PREVALENCE. MS, when moderate to severe, is generally associated with a variable degree of PH ( Table 3 ). The exact prevalence of moderate (14% to 33%) and severe (5.0% to 9.6%) PH varies widely according to studies, the spectrum of MS severities, and symptomatic status (36) (37) (38) . Derived from cardiac catheterization (n ¼ 312; various degrees of MS; unpublished data) (Figure 3 ), 32% of patients had mild Congestive heart failure, acute pulmonary edema, and RV heart failure are the predominant causes of death.
EXERCISE SYSTOLIC PAP IN MS.
In patients with MS, exercise is often accompanied by a rise in LA pressure, transmitral mean pressure gradient, and systolic PAP in response to increased heart rate and flow. compared with the conservative approach) (52). In this series, the vast majority of deaths were from cardiovascular causes and were related to congestive heart failure.
In asymptomatic patients with preserved LV ejection fraction, Magne et al. (10) found that patients with PH had a significantly lower symptom-free survival ( Figure 5B ) (i.e., only one-third of these patients remained free of symptoms at the 2-year follow-up).
As in the study of Kusunose et al. (54) , this relationship was no longer significant after adjustment for age and sex.
EXERCISE PH IN PRIMARY MR. In opposition to resting PH, exercise PH is more prevalent in asymptomatic patients with primary MR and no LV dysfunction/dilation (ejection fraction <60%/endsystolic diameter <40 to 45 mm). In these patients, exercise PH has been associated with significantly lower symptom-free survival (at 2 years 75 AE 7% vs.
35 AE 8%; p < 0.0001) ( Table 3 , Figure 5C ). IMPACT ON OUTCOME. In patients with LV dysfunction, PH is associated with an increased risk of congestive heart failure and mortality (61, 62) . In a large cohort of patients undergoing mitral valve surgery (N ¼ 873) for various etiologies of MR, including functional MR in 31% of cases, Ghoreishi et al. (51) found that PH was associated with worse postoperative outcomes ( Table 3 ). In the study of Agricola et al. (63), systolic PAP was also an independent determinant of heart failure or death. In the absence of planned surgical revascularization, close follow-up is mandatory, and other mitral valve treatments may be discussed. Conversely, in patients with moderate secondary MR and no exercise PH, a medical strategy should be followed.
Although controversial in terms of outcome benefit, the goal of surgical treatment is to reduce MR, prevent its recurrence, and promote LV reverse remodeling.
Restricting annuloplasty may be less effective in patients with severe mitral valve deformation, with a higher risk of residual MR after surgery, which can limit the post-operative improvement in systolic PAP.
In addition, the insertion of a small rigid ring to ach- 
